In our October 2023 issue , we covered the news about the movement towards rescheduling cannabis . That editorial mentioned that in late August 2023 , the Department of Health and Human Services ( DHHS ) formally requested that the DEA consider reclassifying marijuana under the Controlled Substances Act from a Schedule I drug to a Schedule III . At the time , the decision to move cannabis to Schedule III came after a comprehensive year-long investigation by the DHHS . It was long overdue .
Since the 1970s , marijuana has been listed as a Schedule I drug , the same as cocaine , fentanyl , LSD , heroin , and methamphetamine drugs . As of today , marijuana remains in the Schedule I category despite favorable scientific research and being legally sold in 39 states for medical use and 23 states for adult use .
Recently , MoCannTrade announced promising movement on the rescheduling , as featured in an in-depth report by Team Headset . Headset is the leading data analytics company in the cannabis industry with a mission to help businesses make better-informed decisions through data .
The Headset report is titled Unprecedented Support for Cannabis Scheduling Reform Revealed by Data from the DEA Comment Period . The report , in part , stated the following good news .
The DEA ’ s call for public input on cannabis rescheduling garnered an impressive response , with over 42,000 comments submitted . To put this into perspective , that ’ s roughly equivalent to the entire population of Juneau , the capital city of Alaska . It ’ s as if every resident of a small state capital took the time to voice their opinion on this crucial issue .
The unprecedented level of public engagement in this rescheduling proposal underscores the profound importance of cannabis policy reform in the United States . This comment period has shattered previous DEA records , surpassing even the highly contentious 2020 telemedicine rules that garnered approximately 38,000 comments . To put this into perspective , recent DEA proposals typically receive anywhere from a few hundred to around 1,500 comments , even on significant issues like scheduling new substances or adjusting production quotas for controlled substances . The sheer volume of responses – more than tenfold the usual engagement – sends a clear message about the centrality of cannabis policy in current public discourse . It reflects not just the medical and legal complexities surrounding cannabis , but also the deep-rooted social , economic , and personal stakes involved for millions of Americans . This record-breaking participation emphasizes that cannabis rescheduling is not merely a bureaucratic process , but a pivotal moment in U . S . drug policy that has captured the nation ’ s attention and mobilized an extraordinary level of civic engagement .
This level of engagement underscores the significance of the cannabis rescheduling issue to the American public .
The report concluded by saying : As the administration navigates its final months , fast-tracking cannabis rescheduling could serve as a powerful legacy , addressing long standing issues of social justice and medical access . The ball is now in the DEA ’ s court . With public opinion firmly behind rescheduling , and the political stakes higher than ever , all eyes will be on the agency ’ s next moves . Will they heed the call for swift action , or will the process continue at its traditional pace ? The coming months will be crucial in determining the future of cannabis policy in the United States .
Read the full report from Headset at www . headset . io and see Industry Reports .
Meanwhile , the Harvest Moon is on the 17th of this month , and that signals it ’ s time to harvest . So , for the Missouri home-growers , we ’ ve included a few informative articles in this issue with expert tips on how to harvest your home-grown cannabis on pages 12 and 36 . Be sure to check them out .
6 September 2024
From
Bill Cromwell , Publisher
TheEditor
, Editor-in-Chief
Unprecedented Support for Cannabis Rescheduling
MAGAZINE
Missouri ’ s First Educational Medical Cannabis Magazine Published Monthly by Native Kansas City , MO , Advocates , Publishers and Writers . A True Missouri Born Grassroots Effort to Educate and Inform Patients , and to Provide Businesses within The Missouri Cannabis Industry an Economical Forum to Share Their Story . We hope you join and enjoy “ The EVOLUTION .” Since 2019
PUBLISHER , EDITOR-IN-CHIEF : Bill Cromwell News , Articles , Advertisement , & Requests Should Email to : Bill . C @ TheEvolutionMag . com Corporate Office 816.886.9017 Kansas City , MO Mail to : P . O . Box 485 , Grain Valley , MO 64029
MANAGING EDITOR , VP OF OPERATIONS : Victoria Cromwell Subscription inquiries / updates to : Victoria . c @ theevolutionmag . com
DIRECTOR MARKETING and EDITORIAL DEVELOPMENT : Clayton Stallings CREATIVE DESIGNER , GRAPHIC ARTS and EDITORIAL : Bill Cromwell PHOTOGRAPHY : Clayton Stallings , and guests photographers
Our Team of Expert Writers and Cannabis Industry Leaders
● Mitch Alexander ― Product Profiles of The Month
● Danielle Buntyon ― Elevated Learning
● Dana Cunningham — Cooking with CBD and THC
● Ari Fish — Contributing Guest Writer
● Dolores Halbin , RN — Patient Advocate and Awareness
● Tara Holm — Wellness Education
● Peter Kershaw — Health and Wellness Columnist
● Leah Maurer — Cannabis Knowledge , Ask Leah Columnist
● Jay Richardson ― Patient Features
● Monthly Guest Writers — Cannabis News & Feature Stories
The EVOLUTION TM Magazine offers a monthly print magazine that is distributed throughout western Missouri , select St . Louis locations , eastern Kansas and the Lake of the Ozarks region . Free printed copies are found at nearly 360 locations including CBD stores , MMJ Dispensaries , Garden and Grow Supply Stores , doctors offices , restaurants , sports bars , resorts , and many other select locations . In addition , the monthly magazine is offered online in an inter-active E-magazine at www . TheEvolutionMag . com .
NOTICE : The publisher / editor reserves the right to reject whatever material does not fit with the vision or intent of this publication . Advertising is accepted at the discretion of the publisher and do not imply endorsement , nor are we responsible for the products or services advertised . The contributing writers , staff or owners of THE EVOLUTION Magazine LLC cannot be held liable for hardship or losses incurred due to any content associated within this publication or websites . Written views , advertisements and information expressed in this publication belong to the writers or advertisers and do not reflect the sentiments or editorial opinion of the publisher or staff . We cannot be held responsible for ; views , opinions , changes to scheduling , prices , rates or the occasional typographical errors .
ADVERTISEMENT NOTICE : Advertisers have the right to terminate promotions or special offers / coupons , change rates or fees without notice . All listed guides , rates , fees and information herein are non-binding reference material only . Always check with listed businesses or advertisers for its latest updates , current prices and / or special offers .
FDA Disclaimer : Any statements / claims made within this magazine have not been evaluated by the Food and Drug Administration . No articles , products or Ads featured within these pages are intended to diagnose , treat , cure , prevent any disease , ailment or disorder . Medical decisions should not be made based on advertisements within these pages . Consult a physician on the benefits and risks of particular medical marijuana products . Products mentioned within are only for use by adults age 21 and older . Keep such products out of reach of children . The information within is a sharing of knowledge and information based on the writers research , opinions and / or educated experience only .
© 2019 – 2024 The EVOLUTION TM Magazine . All Rights Proprietary and Conceptual Designs Reserved . Reproduction of any part of this publication ’ s contents is strictly prohibited without written permission of the Publisher or Managing Editor .
TM